ACTRN12615001339549招募中3 期
Effect on Migraine Frequency of using Combined Anti-oxidant Therapy: N-acetylcysteine, Vitamin E and Vitamin C (NEC) in adults with frequent migraine: The MIGRANT study.
niversity of Notre Dame Australia0 个研究点目标入组 84 人开始时间: 2015年12月8日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 84
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 65 Years(—)
- 性别
- All
入选标准
- •1. Migraine of at least one year’s duration, with onset before 50 years of age.
- •2. Two-to-eight migraine episodes, and less than six ‘other’ headache types per month, averaged over 12 weeks prior to recruitment.
- •3. Subjects able to clearly distinguish between migraine and ‘other’ headache types.
- •4. Cognitive and English language skills allowing completion of headache diaries and self-administration of trial drugs.
排除标准
- •Participation in a concurrent research trial.
- •1. Chronic daily headaches, according to IHS 2013..Headache Classification Committee of the International Headache Society (IHS).The International Classification of Headache Disorders (3rd Ed) (beta version). Cephalalgia 2013; 33(9): 629–808.
- •2. Medication-overuse headache and/or other primary headache disorders, according to IHS 2013 criteria.
- •3. Change in migraine treatment in the twelve weeks prior to, or during the study.
- •4. Taking 2 or more migraine prevention drugs, .
- •5. Failure to respond in 2 or more previous migraine prevention trials.
- •6. Taking NAc, VitE or VitC supplements in the 12 weeks prior to the study.
- •7. Pregnancy, or risk of pregnancy during the study; female of reproductive age not taking medically prescribed contraception; breast feeding.
- •8. Adverse reactions to NAc, VitE or VitC preparations; VitC deficiency.
- •9. Renal dysfunction (eGFR less than 30 ml/min/1.73m2), liver dysfunction (ALT or AST > 300 IU/L).
- •10. Clinical risks associated with bleeding, coagulopathy, warfarin therapy.
- •11. Haemochromatosis, glucose-6-phosphate dehydrogenase deficiency.
- •12. Daily opioid use in the 12 weeks prior to or during the study.
- •13. Substance abuse, dependence or addiction during the study.
- •14. Psychosis, bipolar affective disorder.
研究者
相似试验
已完成
2 期
Effectiveness of Combo Therapy on Migraine among nursing studentsCTRI/2023/04/051401Pamela Majumder74
招募中
不适用
Study of the effect of MigraineCut drug on migraine headachesMigraineIRCT20170705034915N3MIMDaroo Pharmaceutical Co.492
尚未招募
4 期
Homoeopathic Management in Cases of MigraineCTRI/2024/07/070703RBTS Govt Homoeopathic medical College and Hospital
进行中(未招募)
1 期
Infiltration of the greater occipital nerve (GON) with local anaesthetics and corticosteroids is a treatment option for cluster headache. Corticosteroids may be helpful in reducing the pain intensity and frequency in chronic migrtaine. This RCT is set up to assess efficacy and safety of sub-occipital steroid injections with local anesthetic in patients with chronic migraine.Migraine (chronic)MedDRA version: 19.0Level: HLTClassification code 10027603Term: Migraine headachesSystem Organ Class: 100000004852EUCTR2016-000676-15-DKDanish Headache Center34
已完成
不适用
Adjunctive Treatment of Chronic Migraine Using an Oral Dental DeviceChronic Migraine, HeadacheNCT04871581ChairsideSplint.com25
